Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry

NEW YORK, June 26, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry

http://www.reportlinker.com/p01937761/Drug-Device-Combination-Products-Market-Drug-Eluting-Stents-Infusion-Pumps-Photosensitizers-Orthopedic-Combination-Products-Wound-Care-Combination-Products-Inhalers-Transdermal-Patches-Intraocular-Implants-and-Drug-Eluting-Beads---Global-Industry.html

Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion.

Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report.

Some of the major players profiled in this report are Boston Scientific Corporation, Abbott Laboratories, Allergan, Inc., Bayer Healthcare, Medtronic Inc., Bausch and Lomb, Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Statistical Models
1.3.4 List of Abbreviations
1.3.5 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Definition and Overview
3.2 Market Drivers
3.2.1 Rise in aging population and consequent cases of chronic diseases worldwide
3.2.2 Increasing demand for minimally invasive products
3.3 Market Restraints
3.3.1 Infections from drug device combination products such as implants and associated product recalls
3.4 Market Opportunities
3.4.1 Growth opportunities in emerging economies with high unmet needs
3.4.2 Introduction of biodegradable technology based products
3.5 Porter's Five Forces Analysis: Global Drug Device Combination Products Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by Types

Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion)
4.1 Introduction
4.1.1 Global Drug Device Combination Products Market Revenue, 2011 - 2019 (USD Billion)
4.2 Drug Eluting Stents
4.2.1 Global Drug Eluting Stents Market Revenue, 2011 - 2019 (USD Billion)
4.2.2 Coronary Stents
4.2.2.1 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)
4.2.3 Peripheral Vascular Stents
4.2.3.1 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD Billion)
4.3 Infusion Pumps
4.3.1 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.3.2 Implantable Infusion Pumps
4.3.2.1 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.3.3 Ambulatory Infusion Pumps
4.3.4 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
4.4 Photosensitizers
4.4.1 Global Photosensitizers Market Revenue, 2011-2019 (USD Billion)
4.5 Orthopedic Combination Products
4.5.1 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD Billion)
4.5.2 Antibiotic Bone Cement
4.5.3 Bone Graft Implants
4.6 Wound Care Combination Products
4.6.1 Antibiotic Wound Care Products
4.6.2 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD Billion)
4.7 Inhalers
4.7.1 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.2 Nebulizers
4.7.2.1 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
4.7.3 Metered Dose Inhalers
4.7.3.1 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
4.7.4 Dry Powder Inhalers
4.7.4.1 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
4.8 Transdermal Patches
4.8.1 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
4.9 Other Drug Device Combination Products
4.9.1 Global Other Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
4.9.2 Intraocular Implants
4.9.3 Drug Eluting Beads

Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Drug Device Combination Products Market, by Geography, 2011 - 2019 (USD Billion)
5.1.2 Global Drug Device Combination Products Market, by Geography, 2012 and 2019 (%)
5.2 North America
5.2.1 North America Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
5.5 Rest of the World
5.5.1 RoW Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis: Global Drug Device Combination Products Market
6.1.1 Methodology
6.1.2 Market Share Analysis for the global drug eluting stents market, by key players, 2012
6.1.3 Market share analysis for the global infusion pumps market, by key players, 2012

Chapter 7 Recommendations
7.1 Research and Development Initiatives
7.2 Converging Technologies to Yield Efficiencies
7.3 Mergers and Acquisitions to Improve Market Presence
7.4 Conducting Product Awareness Programs
7.5 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Allergan, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Recent Developments
8.2.5 Business Strategies
8.3 Alcon, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Development
8.4 Arrow International, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Bausch & Lomb, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Recent Developments
8.5.5 Business Strategies
8.6 Boston Scientific Corporation
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.4.1 Acquisitions
8.6.5 Recent Developments
8.7 CareFusion Corporation
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Covidien PLC
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 C.R. Bard, Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Ethicon, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Medline Industries, Inc.
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Medtronic, Inc.
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Development
8.13 Mylan, Inc.
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Pinnacle Biologics, Inc.
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Stryker Corporation
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
8.16 Terumo Corporation
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Business Strategies
8.16.5 Recent Development
8.17 W. L. Gore & Associates, Inc.
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Recent Developments

List of Figures

FIG. 1 Drug Device Combination Products - Market Segmentation
FIG. 2 Global Drug Device Combination Products, 2012, (USD Billion)
FIG. 3 Porter's Five Forces Analysis: Global Drug Device Combination Products Market
FIG. 4 Market Attractiveness Analysis: Global Drug Device Combination Products Market, by Types
FIG. 5 Global Drug Device Combination Products Market Revenue, 2011 – 2019 (USD Billion)
FIG. 6 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Billion)
FIG. 7 Global Coronary Drug Eluting Stents Market, 2011-2019 (USD Billion)
FIG. 8 Global Peripheral Vascular Drug Eluting Stents Market, 2011-2019 (USD Billion)
FIG. 9 Global Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 10 Global Implantable Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 11 Global Ambulatory Infusion Pumps Market Revenue, 2011-2019 (USD Billion)
FIG. 12 Global Photosensitizers Market, 2011-2019 (USD Billion)
FIG. 13 Global Orthopedic Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 14 Global Wound Care Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 15 Global Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 16 Global Nebulizers Market Revenue, 2011-2019 (USD Billion)
FIG. 17 Global Metered Dose Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 18 Global Dry Powder Inhalers Market Revenue, 2011-2019 (USD Billion)
FIG. 19 Global Transdermal Patches Market Revenue, 2011-2019 (USD Billion)
FIG. 20 Global Other Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 21 Comparative Analysis: Global Drug Device Combination Products Market, by Geography
FIG. 22 North America Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 23 Europe Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 24 Asia-Pacific Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 25 RoW Drug Device Combination Products Market Revenue, 2011-2019 (USD Billion)
FIG. 26 Market Share Analysis: Global Drug Eluting Stents Market, by Key Players (2012)
FIG. 27 Market Share Analysis: Global Infusion Pumps Market, by Key Players (2012)
FIG. 28 Abbott Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Allergen, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 30 Alcon, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 32 CareFusion Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 33 Covidien PLC, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 34 C. R. Bard, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 35 Johnson & Johnson, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 36 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 37 Mylan, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 38 Stryker Corporation., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 39 Terumo Corporation., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Drug Device Combination Products Market
TABLE 2 Global Drug Device Combination Products Market, by Geography, 2011 - 2019 (USD Billion)

To order this report: Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry
http://www.reportlinker.com/p01937761/Drug-Device-Combination-Products-Market-Drug-Eluting-Stents-Infusion-Pumps-Photosensitizers-Orthopedic-Combination-Products-Wound-Care-Combination-Products-Inhalers-Transdermal-Patches-Intraocular-Implants-and-Drug-Eluting-Beads---Global-Industry.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.